JPMorgan Chase & Co. reduced its position in shares of Icon PLC (NASDAQ:ICLR) by 58.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 60,528 shares of the company’s stock after selling 84,555 shares during the period. JPMorgan Chase & Co. owned approximately 0.11% of Icon PLC worth $4,237,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Societe Generale bought a new stake in shares of Icon PLC during the second quarter worth approximately $129,000. SG Americas Securities LLC bought a new stake in shares of Icon PLC during the second quarter worth approximately $129,000. Invictus RG bought a new stake in shares of Icon PLC during the first quarter worth approximately $136,000. Creative Planning boosted its stake in shares of Icon PLC by 91.1% in the second quarter. Creative Planning now owns 2,073 shares of the company’s stock worth $145,000 after buying an additional 988 shares during the period. Finally, World Asset Management Inc boosted its stake in shares of Icon PLC by 5.8% in the second quarter. World Asset Management Inc now owns 3,436 shares of the company’s stock worth $241,000 after buying an additional 189 shares during the period. 93.78% of the stock is owned by institutional investors.
Shares of Icon PLC (NASDAQ:ICLR) traded up 0.03% during trading on Friday, hitting $77.06. 403,733 shares of the stock traded hands. The company has a 50-day moving average of $76.65 and a 200-day moving average of $72.33. The firm has a market cap of $4.27 billion, a P/E ratio of 17.81 and a beta of 0.66. Icon PLC has a 52 week low of $62.31 and a 52 week high of $79.80.
Icon PLC (NASDAQ:ICLR) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $1.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.14. The firm earned $411 million during the quarter, compared to the consensus estimate of $409.97 million. Icon PLC had a return on equity of 29.89% and a net margin of 15.70%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.95 EPS. On average, analysts forecast that Icon PLC will post $4.70 EPS for the current fiscal year.
ICLR has been the subject of a number of recent analyst reports. Evercore ISI raised Icon PLC from a “hold” rating to a “buy” rating and upped their price target for the company from $81.50 to $89.00 in a research note on Friday. Zacks Investment Research raised Icon PLC from a “hold” rating to a “buy” rating and set a $87.00 price target for the company in a research note on Wednesday, September 28th. KeyCorp reaffirmed a “buy” rating and issued a $85.00 price target on shares of Icon PLC in a research note on Wednesday, July 27th. Jefferies Group upped their price target on Icon PLC from $78.00 to $80.00 and gave the company a “hold” rating in a research note on Wednesday, July 27th. Finally, Robert W. Baird reissued an “outperform” rating and set a $83.00 target price on shares of Icon PLC in a research note on Monday, June 27th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $80.25.
Icon PLC Company Profile
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon PLC (NASDAQ:ICLR).
Receive News & Ratings for Icon PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon PLC and related companies with MarketBeat.com's FREE daily email newsletter.